First Heartland Consultants’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Heartland Consultants's XBI Position: Q2 2026 in Review

First Heartland Consultants increased its State Street SPDR S&P Biotech ETF (XBI) stake by 1.3% in Q2 2026, buying an estimated $17.3K and bringing the position to 9,709 shares worth $1.54M. The position accounts for 0.1% of the portfolio, ranked #166.

First Heartland Consultants first reported a position in XBI in Q3 2023 and has held it in 12 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

• First Heartland Consultants held 9,709 shares of State Street SPDR S&P Biotech ETF worth $1.54M as of Q2 2026.
• First Heartland Consultants bought 128 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $17.3K.
• State Street SPDR S&P Biotech ETF made up 0.1% of First Heartland Consultants's portfolio in Q2 2026, its #166 holding.
• First Heartland Consultants first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 12 quarters since.
• 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on First Heartland Consultants's 13F filing for Q2 2026, filed 8 Jul 2026.